Churchill Pharmaceuticals LLC Email Format
Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees
Churchill Pharmaceuticals LLC is a small pharmaceutical company focused on developing oral cancer therapies to improve outcomes for patients. Its lead product targets genitourinary cancers, and its pipeline includes additional oral compounds designed to enhance efficacy and safety for people living with cancer. Based in King of Prussia, Pennsylvania, in the greater Philadelphia area, the company maintains a compact team dedicated to its development efforts. In 2017, Churchill Pharmaceuticals announced the launch of its website and signaled plans to bring YONSA (abiraterone acetate) to market for metastatic castration-resistant prostate cancer.